ArticleCancer management and research2022

The Efficacy and Safety of PD-1 Inhibitors Combined with Nab-Paclitaxel Plus Gemcitabine versus Nab-Paclitaxel Plus Gemcitabine in the First-Line Treatment of Advanced Pancreatic Cancer: A Retrospective Monocentric Study.

Feng Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.